EUGCX | VEUSX | EUGCX / VEUSX | |
Total Expense Ratio | 1.90 | 0.08 | 2,375% |
Annual Report Gross Expense Ratio | 2.35 | 0.08 | 2,938% |
Fund Existence | 28 years | 24 years | - |
Gain YTD | 10.246 | 24.037 | 43% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 117M | 32.9B | 0% |
Annual Yield % from dividends | 0.00 | 3.02 | - |
Returns for 1 year | 12.77 | 15.44 | 83% |
Returns for 3 years | 36.36 | 41.82 | 87% |
Returns for 5 years | 5.57 | 46.75 | 12% |
Returns for 10 years | 38.61 | 49.42 | 78% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FLCH | 23.60 | 0.24 | +1.03% |
Franklin FTSE China ETF | |||
FMED | 24.26 | 0.22 | +0.90% |
Fidelity Disruptive Medicine ETF | |||
IRVH | 20.80 | N/A | N/A |
Global X Interest Rt Vol & Infl Hdg ETF | |||
RWK | 121.07 | -0.67 | -0.55% |
Invesco S&P MidCap 400 Revenue ETF | |||
VGT | 700.05 | -4.42 | -0.63% |
Vanguard Information Technology ETF |